adenoviral vector (Ad-5)-based therapeutic HBV vaccine (Transgene)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameadenoviral vector (Ad-5)-based therapeutic HBV vaccine (Transgene)
Drug Alias NameAdTG-18202Ad-HBVAdTG-17910AdTG-17909
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTransgene Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransgene Sa
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A